Rituxan

Related to the last update, Genentech announced that they are not going ahead with rituxan for RRMS (they are continuing with the PPMS trial). The reason is that ocrelizumab goes after the same target and they are concentrating on that drug for RRMS. I removed Rituxan from the phase 2 list.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: